Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
S. Verhulst (Wilrijk, Belgium). Effects of OSA on metabolic dysfunction in adolescents - is OSA relevant for adolescent obesity?. Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options

Member's Comments

No comment yet.

Related content which might interest you: Effects of OSA on metabolic dysfunction in children Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Genetic factors: OSAS, obesity or both? Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Introduction and epidemiology of dyslipidemia in OSAS patients Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Data from animal models: role of IH and obesity Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Does sleep loss play a role in adipose tissue dysfunction? Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 CPAP treatment: effects on plasma lipids and liver function Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Inflammation in obese adipose tissue Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Visceral adipose tissue as a target for therapeutic intervention: an update Source: Research Seminar 2009 - Intermittent hypoxia and adipose tissue - Insight into the pathophysiology of the Obstructive Sleep Apnoea Syndrome (OSAS) and treatment options Year: 2009 Metabolic consequences in obstructive sleep apnoea Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts Year: 2006 Does the neutrophil-to-lymphocyte ratio have any importance between subjects with obstructive sleep apnea syndrome with obesity and without obesity? Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea Year: 2016 Is desaturation Index, a better predictor of metabolic syndrome than apnoea-hypopnoea index? Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea Year: 2016 Anthropometric markers of adiposity and visceral adiposity index (VAI) in patients with OSA Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013 Physiological correlates to physical activity in obese patients with obstructive sleep apnea (OSA) Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013 Frequency and predictors of obesity hypoventilation syndrome in morbidly obese (BMI ≥40) patients with obstructive sleep apnea syndrome Source: Annual Congress 2013 –Sleep disordered breathing in special situations II Year: 2013 Risk for asthma is associated with higher BMI, but not with obesity? Source: International Congress 2015 – More paediatric asthma and allergy Year: 2015 Obstructive sleep apnea syndrome in obese patients: adiponectin levels Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 Prevalence of arterial hypertension in obstructive sleep apnoea (OSA) patients – Impact of diabetes and obesity Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013